Molecular profiling of breast cancer broadly classifies breast cancer into hormonal receptor positive and negative breast cancer based on the presence or absence of three key bio-markers; the estrogen receptor (ER); the progesterone receptor (PR); and the human epidermal growth factor-2 (HER2) receptor [4]. Here, NR4A1 is linked to breast carcinoma.